Arcellx, Inc. (ACLX)

NASDAQ: ACLX · Real-Time Price · USD

64.31

-0.70 (-1.08%)

At close: Jan 8, 2026, 4:00 PM EST

64.37

+0.06 (0.09%)

After-hours: Jan 8, 2026, 5:07 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cell Therapies	107.94M	Log In
Cell Therapies Growth	-2.16%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	107.94M	Log In
United States Growth	-2.16%	Log In